Therapeutic androgen receptor ligands
Open Access
- 1 January 2003
- journal article
- Published by SAGE Publications in Nuclear Receptor Signaling
- Vol. 1 (1) , e009
- https://doi.org/10.1621/nrs.01009
Abstract
In the past several years, the concept of tissue-selective nuclear receptor ligands has emerged. This concept has come to fruition with estrogens, with the successful marketing of drugs such as raloxifene. The discovery of raloxifene and other selective estrogen receptor modulators (SERMs) has raised the possibility of generating selective compounds for other pathways, including androgens (that is, selective androgen receptor modulators, or SARMs).Keywords
This publication has 17 references indexed in Scilit:
- A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic womenClinical Endocrinology, 2002
- Bicalutamide as Immediate Therapy Either Alone or as Adjuvant to Standard Care of Patients with Localized or Locally Advanced Prostate Cancer: First Analysis of the Early Prostate Cancer ProgramJournal of Urology, 2002
- Androgen Receptor (AR) Coregulators: An OverviewEndocrine Reviews, 2002
- New alternative treatment in hirsutism: bicalutamide 25 mg/dayGynecological Endocrinology, 2002
- Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosteroneProceedings of the National Academy of Sciences, 2001
- Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen ReceptorJournal of Biological Chemistry, 2000
- A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of HirsutismJournal of Clinical Endocrinology & Metabolism, 1999
- Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071)Journal of Medicinal Chemistry, 1999
- Evaluation of RU58841 as an Anti-Androgen in Prostate PC3 Cells and a Topical Anti-Alopecia Agent in the Bald Scalp of Stumptailed MacaquesEndocrine, 1998
- Potent novel nonsteroidal androgen antagonists with a phthalimide skeletonBioorganic & Medicinal Chemistry Letters, 1997